Hydrogen peroxide-induced translocation of glycolipid-anchored (c)AMP-hydrolases to lipid droplets mediates inhibition of lipolysis in rat adipocytes

British Journal of Pharmacology

Volumn 154, Issue 4, 2008, Pages 901-913

  Muller G ^a   Wied, S ^a   Jung, C ^a   Over, S ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Adipocytes; Glycosylphosphatidylinositol anchored proteins; Lipid droplets; Lipolysis; Reactive oxygen species; Sulphonylureas

Indexed keywords

5' NUCLEOTIDASE; CYCLIC AMP; FAT DROPLET; GLIMEPIRIDE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HYDROGEN PEROXIDE; HYDROLASE; INSULIN; PALMITIC ACID; PHOSPHOLIPASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; LIPOLYSIS; NONHUMAN; OXIDATIVE STRESS; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

5'-NUCLEOTIDASE; ADIPOCYTES; ANIMALS; CYCLIC AMP; FATTY ACIDS; GLYCOSYLPHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; GLYCOSYLPHOSPHATIDYLINOSITOLS; HYDROGEN PEROXIDE; LIPOLYSIS; MEMBRANE MICRODOMAINS; NADPH OXIDASE; PROTEIN TRANSPORT; RATS; REACTIVE OXYGEN SPECIES; SULFONYLUREA COMPOUNDS;

EID: 44949151521     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.146     Document Type: Article

References (60)

1. Bedard K, Krause KH (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313.
2. Bellin C, de Wiza DH, Wiernsperger NF, Rösen P (2006). Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin. Horm Metab Res 38: 732-739.
3. Brownlee M (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.
4. Davis SN (2004). The role of glimepiride in the effective management of type 2 diabetes. J Diabetes Complications 18: 367-376.
5. Frisard M, Ravussin E (2006). Energy metabolism and oxidative stress: impact on the metabolic syndrome and the ageing process. Endocrine J 29: 27-32.
6. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 12: 1752-1761.
7. Giorgio M, Trinei M, Migliaccio E, Pelicci PG (2007). Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nature Rev 8: 722-728.
8. Goldstein BJ, Mahadev K, Wu X (2005). Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signalling targets. Diabetes 54: 311-321.
9. Guo W, Xie W, Han J (2006). Modulation of adipocyte lipogenesis by octanoate: involvement of reactive oxygen species. Nutr Metab (Lond) 3: 30.
10. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK (2004). Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683.
11. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M et al. (2000). High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945.
12. Jepson CA, Yeaman SJ (1992). Inhibition of hormone-sensitive lipase by intermediary lipid metabolites. FEBS Lett 310: 197-200.
13. Jones DR, Varela-Nieto I (1998). Diabetes and the role of inositol-containing lipids in insulin signaling. Mol Med 5: 505-514.
14. Kadri-Hassani N, Leger CL, Descomps B (1995). The fatty acid bimodal action on superoxide anion production by human adherent monocytes under phorbol 12-myristate 13-acetate or diacylglycerol activation can be explained by the modulation of protein kinase C and p47phox translocation. J Biol Chem 270: 15111-15118.
15. Kather H, Wieland E, Waas W (1987). Chemiluminescent determination of adenosine, inosine, and hypoxanthine xanthine. Anal Biochem 163: 45-51.
16. Korytkowski MT (2004). Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride. Pharmacotherapy 24: 606-620.
17. Koshiba K, Nomura M, Nakaya Y, Ito S (2006). Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis. J Med Invest 53: 87-94.
18. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89: 1006-1013.
19. 2 generation in 3T3-L1 cells. Biochem J 307: 549-556.
20. Lehtihet M, Welsh N, Berggren PO, Cook GA, Sjoholm A (2003). Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis. Am J Physiol Endocrinol Metab 285: E438-E446.
21. Lei T, Xie W, Han J, Corkey BE, Hamilton JA, Guo W (2004). Medium-chain fatty acids attenuate agonist-stimulated lipolysis, mimicking the effects of starvation. Obesity Res 12: 599-611.
22. Li JM, Shah AM (2002). Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277: 19952-19960.
23. Little SA, de Haen C (1980). Effects of hydrogen peroxide on basal and hormone-stimulated lipolysis in perifused rat fat cells in relation to the mechanism of action of insulin. J Biol Chem 255: 10888-10895.
24. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24: 1844-1854.
25. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, Goldstein BJ (2001). Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669.
26. Maragno I, Dorigo P, Fassina G (1971). Effect of antimycin A on hormone-stimulated lipolysis in vitro. Biochem Pharmacol 20: 2149-2154.
27. Matsuki M, Matsuda M, Kohara K, Shimoda M, Kanda Y, Tawaramoto K et al. (2007). Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once-versus twice-daily dosing. Endocrine J 54: 571-576.
28. Meng TC, Buckley DA, Galic S, Tiganis T, Tonks NK (2004). Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J Biol Chem 279: 37716-37725.
29. Meng TC, Fukada T, Tonks NK (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399.
30. Morgan D, Oliveira-Emilio HR, Keane D, Hirata AE, Santos da Rocha M, Bordin S et al. (2007). Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. Diabetologia 50: 359-369.
31. Movahedi S, Hooper N (1997). Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C. Biochem J 326: 531-537.
32. Muchmore DB, Little SA, de Haen C (1982). Counterregulatory control of intracellular hydrogen peroxide production by insulin and lipolytic hormones in isolated rat epididymal fat cells: a role of free fatty acids. Biochemistry 21: 3886-3892.
33. Mukherjee SP (1980). Mediation of the antilipolytic and lipogenic effects of insulin in adipocytes by intracellular accumulation of hydrogen peroxide. Biochem Pharmacol 29: 1239-1246.
34. Müller G (2005). The mode of action of glimepiride - beyond insulin secretion. Curr Med Chem 5: 499-518.
35. Müller G, Dearey E-A, Korndörfer A, Bandlow W (1994a). Stimulation of a glycosyl phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport. J Cell Biol 126: 1267-1276.
36. Müller G, Dearey E-A, Pünter J (1993). The sulphonylurea drug, glimepiride, stimulates release of glycosylphosphatidylinositol-anchored plasma-membrane proteins from 3T3 adipocytes. Biochem J 289: 509-521.
37. Müller G, Hanekop N, Wied S, Frick W (2002). Cholesterol depletion blocks redistribution of lipid raft components and insulin-mimetic signaling by glimepiride and phosphoinositolglycans in rat adipocytes. Mol Med 8: 120-136.
38. Müller G, Jordan H, Jung C, Kleine H, Petry S (2003). Analysis of lipolysis in adipocytes using a fluorescent fatty acid derivative. Biochimie 85: 1245-1256.
39. Müller G, Jung C, Wied S, Welte S, Jordan H, Frick W (2001). Redistribution of glycolipid raft domain components induces insulin-mimetic signaling in rat adipocytes. Mol Cell Biol 21: 4553-4567.
40. 2 and the sulfonylurea drug, glimepiride, in rat adipocytes. Biochemistry 47: 1274-1287.
41. Müller G, Petry S (2005). Triacylglycerol, storage and mobilization of human. In: Meyers A (ed). Encyclopedia in Biochemistry and Molecular Biology, vol 14. Wiley-VCH: Weinheim, Germany. pp 621-704.
42. Müller G, Schulz A, Wied S, Frick W (2005). Regulation of lipid raft proteins by glimepiride- and insulin-induced glycosylphosphati-dylinositol- specific phospholipase C in rat adipocytes. Biochem Pharmacol 69: 761-780.
43. Müller G, Wetekam E-M, Jung C, Bandlow W (1994b). Membrane association of lipoprotein lipase and a cAMP-binding ectoprotein in rat adipocytes. Biochemistry 33: 12149-12159.
44. 2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets. Biochemistry 47: 1259-1273.
45. 2 and the sulfonylurea drug, glimepiride. Mol Pharmacol 73: 1513-1529.
46. Müller G, Wied S, Wetekam E-M, Crecelius A, Unkelbach A, Pünter J (1994c). Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulfonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade. Biochem Pharmacol 48: 985-996.
47. Park HS, Jin DK, Shin SM, Jang MK, Longo N, Park JW et al. (2005). Impaired generation of reactive oxygen species in leprechaunism through downregulation of Nox4. Diabetes 54: 3175-3181.
48. Quinn MT, Ammons MCB, DeLeo FR (2006). The expanding role of NADPH oxidases in health and disease. No longer just agents of death and destruction. Clin Sci 111: 1-20.
49. Spurway TD, Pogson CI, Sherratt HS, Agius L (1997). Etomoxir, sodium 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate, inhibits triacylglycerol depletion in hepatocytes and lipolysis in adipocytes. FEBS Lett 404: 111-114.
50. Stralfors P (1997). Insulin second messengers. BioEssays 19: 327-335.
51. Talior I, Yarkoni M, Bashan N, Eldar-Finkelman H (2003). Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice. Am J Physiol Endocrinol Metab 285: E295-E302.
52. Terada LS (2006). Specificity in reactive oxidant signalling: think globally, act locally. J Cell Biol 174: 615-623.
53. Thomasz L, Aran M, Pizarro RA, Ibanez J, Pisarev MA, Converso D et al. (2007). Inhibition of peroxidase and catalase activities and modulation of hydrogen peroxide level by inositol phosphoglycan-like compounds. Horm Metab Res 39: 14-19.
54. Tsubouchi H, Inoguchi T, Inuo M, Kakimoto M, Sonta T, Sonoda N et al. (2005). Sulfonylurea as well as elevated glucose levels stimulate reactive oxygen species production in the pancreatic β-cell line, MIN6 - a role of NAD(P)H oxidase in β-cells. Biochem Biophys Res Commun 326: 60-65.
55. Ushio-Fukai M (2006). Localizing NADPH oxidase-derived ROS. Sci STKE 2006: re8.
56. Vallano ML, Lee MY, Sonenberg M (1983). Hormones modulate adipocyte membrane potential, ATP and lipolysis by free fatty acids. Am J Physiol 245: E266-E272.
57. Vilhardt F, van Deurs B (2004). The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J 23: 739-748.
58. Wang H, Joseph JA (1999). Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27: 612-616.
59. Yeaman SJ (2004). Hormone-sensitive lipase: new roles for an old enzyme. Biochem J 379: 11-22.
60. Zhang AY, Yi F, Zhang G, Gulbins E, Li PL (2006). Lipid raft clustering and redox signalling platform formation in coronary arterial endothelial cells. Hypertension 47: 74-80.